The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
The war against influenza: discovery and development of sialidase inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690
Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin
Skehel, J. J., & Wiley, D. C. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.531 · Cited by 2,706
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,634
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution
Wilson, I. A., Skehel, J. J., & Wiley, D. C. (1981) · Nature · doi:10.1038/289366a0 · Cited by 2,525
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Influenza virus M2 protein has ion channel activity
Pinto, L. H., Holsinger, L. J., & Lamb, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90452-i · Cited by 1,213
Principles and practice of infectious disease
Cann, K. J. (1990) · Journal of Hospital Infection · doi:10.1016/0195-6701(90)90013-e · Cited by 1,199
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid
Weis, W., Brown, J. H., Cusack, S., Paulson, J. C., Skehel, J. J., & Wiley, D. C. (1988) · Nature · doi:10.1038/333426a0 · Cited by 1,158
Kim, C. U., Lew, W., Williams, M. A., Liu, H., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M. S., Mendel, D. B., Tai, C. Y., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963036t · Cited by 1,100
Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution
Varghese, J. N., Laver, W. G., & Colman, P. M. (1983) · Nature · doi:10.1038/303035a0 · Cited by 891
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Russell, R. J., Haire, L. F., Stevens, D. J., Collins, P. J., Lin, Y. P., Blackburn, G. M., Hay, A. J., Gamblin, S. J., & Skehel, J. J. (2006) · Nature · doi:10.1038/nature05114 · Cited by 813
Structure of the catalytic and antigenic sites in influenza virus neuraminidase
Colman, P. M., Varghese, J. N., & Laver, W. G. (1983) · Nature · doi:10.1038/303041a0 · Cited by 798
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase
Palese, P., Tobita, K., Ueda, M., & Compans, R. W. (1974) · Virology · doi:10.1016/0042-6822(74)90276-1 · Cited by 789
Influenza vaccine: The challenge of antigenic drift
CARRAT, F., & FLAHAULT, A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.027 · Cited by 708
Isolation of drug-resistant H5N1 virus
Le, Q. M., Kiso, M., Someya, K., Sakai, Y. T., Nguyen, T. H., Nguyen, K. H. L., Pham, N. D., Ngyen, H. H., Yamada, S., Muramoto, Y., et al. (2005) · Nature · doi:10.1038/4371108a · Cited by 693
Functional balance between haemagglutinin and neuraminidase in influenza virus infections
Wagner, R., Matrosovich, M., & Klenk, H. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.352 · Cited by 608
Options for the control of influenza III
Ada, G. L., Tannock, G. A., & Hampson, A. W. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00191-0 · Cited by 587
Sialic Acid Species as a Determinant of the Host Range of Influenza A Viruses
Suzuki, Y., Ito, T., Suzuki, T., Holland, R. E., Chambers, T. M., Kiso, M., Ishida, H., & Kawaoka, Y. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11825-11831.2000 · Cited by 512
Maines, T. R., Lu, X. H., Erb, S. M., Edwards, L., Guarner, J., Greer, P. W., Nguyen, D. C., Szretter, K. J., Chen, L.-M., Thawatsupha, P., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11788-11800.2005 · Cited by 455
Varghese, J. N., McKimm‐Breschkin, J. L., Caldwell, J. B., Kortt, A. A., & Colman, P. M. (1992) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340140302 · Cited by 402
Babu, Y. S., Chand, P., Bantia, S., Kotian, P., Dehghani, A., El-Kattan, Y., Lin, T.-H., Hutchison, T. L., Elliott, A. J., Parker, C. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002679 · Cited by 384
Liu, C., Eichelberger, M. C., Compans, R. W., & Air, G. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1099-1106.1995 · Cited by 367
Influenza virus neuraminidase: Structure, antibodies, and inhibitors
Colman, P. M. (1994) · Protein Science · doi:10.1002/pro.5560031007 · Cited by 333
Woods, J. M., Bethell, R. C., Coates, J. A., Healy, N., Hiscox, S. A., Pearson, B. A., Ryan, D. M., Ticehurst, J., Tilling, J., & Walcott, S. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1473 · Cited by 312
(1995) · Springer eBooks · doi:10.1007/978-1-4757-9504-2 · Cited by 302
Structure−Activity Relationship Studies of Novel Carbocyclic Influenza Neuraminidase Inhibitors
Kim, C. U., Lew, W., Williams, M. A., Wu, H., Zhang, L., Chen, X., Escarpe, P. A., Mendel, D. B., Laver, W. G., & Stevens, R. C. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980162u · Cited by 291
Comprehensive glycoscience: from chemistry to systems biology
(2008) · Choice Reviews Online · doi:10.5860/choice.45-4385 · Cited by 246
OXFORD, J. S. (2000) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(200003/04)10:2<119::aid-rmv272>3.0.co;2-o · Cited by 223
Prophylaxis and Treatment of Influenza
Oates, J. A., Wood, A. J. J., & Douglas, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220706 · Cited by 209
Taylor, N. R., & von Itzstein, M. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00031a011 · Cited by 203
Self-citationVarghese, J. N., Chandana Epa, V., & Colman, P. M. (1995) · Protein Science · doi:10.1002/pro.5560040606 · Cited by 199
CHONG, A. K. J., PEGG, M. S., TAYLOR, N. R., & von ITZSTEIN, M. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17055.x · Cited by 178
Self-citationHuman infection by avian influenza A H5N1.
Yuen, K., & Wong, S. S. Y. (2005) · PubMed · Cited by 168
Ilyushina, N. A., Bovin, N. V., Webster, R. G., & Govorkova, E. A. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.01.012 · Cited by 157
Holzer, C. T., von Itzstein, M., Jin, B., Pegg, M. S., Stewart, W. P., & Wu, W.-Y. (1993) · Glycoconjugate Journal · doi:10.1007/bf00731185 · Cited by 155
Influenza B virus neuraminidase can synthesize its own inhibitor
Burmeister, W. P., Henrissat, B., Bosso, C., Cusack, S., & Ruigrok, R. W. H. (1993) · Structure · doi:10.1016/0969-2126(93)90005-2 · Cited by 152
von Itzstein, M., Wu, W.-Y., & Jin, B. (1994) · Carbohydrate Research · doi:10.1016/0008-6215(94)84065-2 · Cited by 148
Natural and synthetic sialic acid‐containing inhibitors of influenza virus receptor binding
Matrosovich, M. N., & Klenk, H. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.372 · Cited by 148
Structure and Diversity of Influenza Virus Neuraminidase
Colman, P. M., & Ward, C. W. (1985) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-70227-3_5 · Cited by 139
Viral and Bacterial Neuraminidases
Drzeniek, R. (1972) · Modern aspects of electrochemistry · doi:10.1007/978-3-642-65444-2_2 · Cited by 134
Influenza A/H5N1 virus infection in humans in Cambodia
Buchy, P., Mardy, S., Vong, S., Toyoda, T., Aubin, J., Miller, M., Touch, S., Ly, S., Dufourcq, J., Richner, B., et al. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.04.010 · Cited by 125
von Itzstein, M., Dyason, J. C., Oliver, S. W., White, H. F., Wu, W.-Y., Kok, G. B., & Pegg, M. S. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950294c · Cited by 115
Palese, P., Schulman, J. L., Bodo, G., & Meindl, P. (1974) · Virology · doi:10.1016/0042-6822(74)90458-9 · Cited by 113
Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor
Watowich, S. J., Skehel, J. J., & Wiley, D. C. (1994) · Structure · doi:10.1016/s0969-2126(00)00073-3 · Cited by 111
Rimantadine: A Clinical Perspective
Wintermeyer, S. M., & Nahata, M. C. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502900312 · Cited by 85
Li, C., Yu, Q., Ye, Z., Sun, Y., He, Q., Li, X.-M., Zhang, W., Luo, J., Gu, X., Zheng, X., et al. (2007) · Cell Research · doi:10.1038/cr.2007.27 · Cited by 75
Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention
Clercq, E. D., & Neyts, J. H. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.04.005 · Cited by 71
NÖHLE, U., Beau, J., & Schauer, R. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb06815.x · Cited by 68
Antiviral Therapy Targeting Viral Polymerase
Tsai, C., Lee, P.-Y. A., Stollar, V., et al. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776361156 · Cited by 58
Sialic Acid as Receptor Determinant of Ortho- and Paramyxoviruses
Herrler, G., Hausmann, J., & Klenk, H. (1995) · Springer eBooks · doi:10.1007/978-1-4757-9504-2_9 · Cited by 46
Pandemic influenza: its origin and control
Laver, G. W., & Garman, E. F. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)00013-8 · Cited by 42
Hasegawa, H., Ichinohe, T., Tamura, S., & Kurata, T. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.2.193 · Cited by 30
The interaction of substrate-related ketals with bacterial and viral neuraminidases
Flashner, M., Kessler, J., & Tanenbaum, S. W. (1983) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(83)90135-2 · Cited by 28
Neuraminidase inhibitors as antivirals
Colman, P. M. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00132-9 · Cited by 19
Effect of substrate aglycon on enzyme mechanism in the reaction of sialidase from influenza virus
Tiralongo, J., Pegg, M. S., & von Itzstein, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00967-e · Cited by 18
Cited by
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Clausen, T. M., Sandoval, D. R., Spliid, C. B., Pihl, J., Perrett, H. R., Painter, C. D., Narayanan, A., Majowicz, S. A., Kwong, E. M., McVicar, R. N., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.033 · Cited by 1,136
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Cu-Catalyzed Click Reaction in Carbohydrate Chemistry
Tiwari, V. K., Mishra, B. B., Mishra, K. B., Mishra, N., Singh, A. S., & Chen, X. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00408 · Cited by 862
From carbohydrate leads to glycomimetic drugs
Ernst, B., & Magnani, J. L. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2852 · Cited by 820
Schnaar, R. L., Gerardy-Schahn, R., & Hildebrandt, H. (2014) · Physiological Reviews · doi:10.1152/physrev.00033.2013 · Cited by 745
Metadata
- Authors
- von Itzstein, M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-12
- Volume
- 6
- Issue
- 12
- Pages
- 967-974
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2050205112
- Cited by
- 702
- References
- 56
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.